Terra Nova Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Terra Nova Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-720	Closed	-$349K	–	91
2025 Q1	$349K	Hold	720	–	–	0.27%	67
2024 Q4	$290K	Sell	720 -1	-0.1%	-$464	0.22%	76
2024 Q3	$335K	Hold	721	–	–	0.25%	73
2024 Q2	$338K	Buy	721 +64	+10%	+$27.8K	0.27%	69
2024 Q1	$275K	Buy	657 +75	+13%	+$31.7K	0.22%	79
2023 Q4	$237K	Buy	+582	New	+$215K	0.21%	80

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Terra Nova Asset Management's VRTX Position: Q2 2025 in Review

Terra Nova Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 720 shares — an estimated $349K sold.

Terra Nova Asset Management first reported a position in VRTX in Q4 2023 and held it in 6 quarters. The position peaked at $349K in Q1 2025. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

Terra Nova Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Terra Nova Asset Management sold 720 Vertex Pharmaceuticals shares in Q2 2025, an estimated $349K.
Terra Nova Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Terra Nova Asset Management's Vertex Pharmaceuticals position peaked at $349K in Q1 2025.
1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Terra Nova Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.